Accepted for Publication: July 4, 2022.
Published Online: August 25, 2022. doi:10.1001/jamaophthalmol.2022.3234
Corresponding Author: Rasmus Gregersen, MD, Akutmodtagelsen, Bispebjerg Hospital, Ebba Lunds Vej 40A, bygning 67, 2. sal, 2400 Copenhagen, Denmark (rasmus.gregersen@regionh.dk).
Author Contributions: Ms Jacobsen and Dr Petersen had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.
Concept and design: Jacobsen, Laursen, Iversen, Petersen.
Acquisition, analysis, or interpretation of data: Gregersen, Jacobsen, Laursen, Mobech, Ostrowski, Iversen, Petersen.
Drafting of the manuscript: Gregersen, Laursen, Petersen.
Critical revision of the manuscript for important intellectual content: Jacobsen, Laursen, Mobech, Ostrowski, Iversen, Petersen.
Statistical analysis: Jacobsen.
Obtained funding: Laursen, Iversen.
Administrative, technical, or material support: Gregersen, Laursen, Ostrowski.
Supervision: Gregersen, Laursen, Mobech, Ostrowski, Iversen, Petersen.
Conflict of Interest Disclosures: None reported.
Funding/Support: This work was financially supported by the Lundbeck Foundation (grant R349-2020-1172) and Falck A/S.
Role of the Funder/Sponsor: Falck A/S was involved in the design and conduct of the study, collection of the data, review and approval of the manuscript, and decision to submit the manuscript for publication. The Lundbeck Foundation was not involved in any parts of the study.
Additional Contributions: Jakob Riis, PhD (University of Copenhagen; CEO and president of Falck A/S), contributed to the study design (no compensation was received for study-related work). Camille Løve Andersen, BSc (project nurse at Falck A/S), contributed to data collection (no compensation was received for study-related work). Henrik Ullum, PhD (University of Copenhagen and CEO of Statens Serum Institut), contributed to study design, obtaining approvals, study initiation, and funding acquisition (compensation was not received).